Soluble CD163: An age-dependent, anti-inflammatory biomarker predicting outcome in sepsis*
- 1 October 2006
- journal article
- editorial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 34 (10) , 2682-2683
- https://doi.org/10.1097/01.ccm.0000240242.10583.86
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163*Critical Care Medicine, 2006
- PERIPHERAL HEMOPHAGOCYTOSISShock, 2006
- Differential maturation of murine bone-marrow derived dendritic cells with lipopolysaccharide and tumor necrosis factor-αInnate Immunity, 2005
- Interleukin‐4 and Dexamethasone Counterregulate Extracellular Matrix Remodelling and Phagocytosis in Type‐2 MacrophagesScandinavian Journal of Immunology, 2005
- Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients—A postmortem clinicopathologic analysisCritical Care Medicine, 2004
- Modern management of children with haemophagocytic lymphohistiocytosisBritish Journal of Haematology, 2003
- Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell–induced apoptosisBlood, 2002
- Bone marrow biopsy in hemophagocytic syndromeVirchows Archiv, 2002
- HUMAN MONOCYTES EXPRESS CD163, WHICH IS UPREGULATED BY IL-10 AND IDENTICAL TO p155Cytokine, 2000
- A new macrophage differentiation antigen which is a member of the scavenger receptor superfamilyEuropean Journal of Immunology, 1993